Reprint of "Decline in platelet count and long-term post-PCI ischemic events: implication of the intra-aortic balloon pump".

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Vascular pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vph.2014.03.003PMID 24657382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age- And Sex-Related Variations in Platelet Count in Italy: A Proposal of Reference Ranges Based on 40987 Subjects' Data

  2013cited by this paper
• Third universal definition of myocardial infarction.

  2012cited by this paper
• Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.

  2011cited by this paper
• Determinants of 40-year all-cause mortality in the European cohorts of the Seven Countries Study

  2011cited by this paper
• Acquired disorders of platelet function.

  2011cited by this paper
• Defective recovery of QT dispersion predicts late cardiac mortality after percutaneous coronary intervention

  2011cited by this paper
• Safety of downstream high-dose tirofiban bolus among 1578 patients undergoing percutaneous coronary intervention: the Sant'ANna TIrofiban Safety study

  2010cited by this paper
• Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors.

  2010cited by this paper
• Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration.

  2010cited by this paper
• Platelet count and the risk for thrombosis and death in the elderly

  2009cited by this paper
• Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice

  2009cited by this paper
• Occurrence, predictors, and outcomes of post-percutaneous coronary intervention thrombocytopenia in an unselected population.

  2009cited by this paper
• Bivalirudin during primary PCI in acute myocardial infarction.

  2008cited by this paper
• Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation.

  2008cited by this paper
• Age and QT variability index during free breathing, controlled breathing and tilt in patients with chronic heart failure and healthy control subjects.

  2006cited by this paper
• Percutaneous Interventions in the Coagulopathic Patient

  2005cited by this paper
• Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.

  2005cited by this paper
• Simvastatin‐induced thrombocytopenia

  2001cited by this paper
• Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) Study

  2001cited by this paper
• Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.

  2000cited by this paper
• Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis.

  2000cited by this paper
• Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience.

  1999cited by this paper
• Atorvastatin-induced severe thrombocytopenia.

  1998cited by this paper
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

  1998cited by this paper
• Association of thrombocytopenia with the use of intra-aortic balloon pumps.

  1998cited by this paper
• Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group.

  1998cited by this paper
• Thrombotic thrombocytopenic purpura and simvastatin.

  1998cited by this paper
• Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.

  1997cited by this paper
• Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

  1994cited by this paper
• Thrombocytopenia induced by angiotensin converting enzyme inhibitors.

  1989cited by this paper
• Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease.

  1986cited by this paper

• No citing papers are available for this paper.